Based on her experience, Maria Lopes, MD, MS, explains that many large employers are adopting a value-based healthcare system. She notes that this may be because larger employers are focused on the long-term benefits of prevention and wellness.
Dr Lopes explains that while some employers offer incentives for meeting certain minimum criteria (eg, getting health risk appraisals), others incorporate value-based benefit designs. In some cases, employers punish employees with disincentives, such as increasing the employee share of the premium increases.
Yehuda Handelsman, MD, FACP, FACE, FNLA, explains that as a result of provider- focused pay-for-performance models of care, physicians may try to avoid treating certain higher-risk patient groups. Dr Handelsman explains that if a physician does not believe that an outcome of improvement for a patient or patient group is possible, there is no incentive to manage them. Jeffrey D. Dunn, PharmD, MBA, notes that most pay-for-performance models are incentive based.
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Makers of medical tests will have about 4 years to show the FDA that their new offerings deliver accurate results; after previously decreasing for 27 years, US tuberculosis (TB) cases increased every year since 2020; a US district judge rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to the Medicare drug price negotiation program.
Read More